Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance

Glioblastoma (GBM) is the most common and aggressive primary brain tumor and is nearly universally fatal. Targeted therapy and immunotherapy have had limited success in GBM, leaving surgery, alkylating chemotherapy and ionizing radiation as the standards of care. Like most cancers, GBMs rewire metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Weihua, Wahl, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770393/
https://www.ncbi.nlm.nih.gov/pubmed/31450721
http://dx.doi.org/10.3390/cancers11091231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770393/
https://www.ncbi.nlm.nih.gov/pubmed/31450721
http://dx.doi.org/10.3390/cancers11091231

Ejemplares similares